Skip to main content
SpringerLink
Log in

Major Depression and Metabolic Encephalopathy: Syndromes More Alike Than Not?

  • Chapter
  • First Online:
Metabolic Encephalopathy

  • 1025 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahboucha, S. and Butterworth, R.F. 2007. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy. Metab. Brain Dis. 22:291–308.

    Article  PubMed  CAS  Google Scholar 

  • Albrecht, J. and Jones, E.A. 1999. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci. 170:138–146.

    Article  PubMed  CAS  Google Scholar 

  • Altamura, C., Maes, M., Dai, J., and Meltzer, H.Y. 1995. Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. Eur. Neuropsychopharmacol. 5:71–75.

    Article  PubMed  CAS  Google Scholar 

  • Bansky, G., Meier, P.J., Ziegler, W.H., Walser, H., Schmid, M., and Huber, M. 1985. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1:132–1325.

    Google Scholar 

  • Barbosa, L., Berk, M., and Vorster, M. 2003. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J. Clin. Psychiatry 64:403–407.

    Article  PubMed  CAS  Google Scholar 

  • Basile, A.S., Hughes, R.D., Harrison, P.M., Murata, Y., Pannell, L., Jones, E.A., Williams, R., and Skolnick, P. 1991. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N. Engl. J. Med. 325:473–478.

    Article  PubMed  CAS  Google Scholar 

  • Bassett, M.L., Mullen, K.D., Skolnick, P., and Jones, E.A. 1987. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Gastroenterology 93:1069–1077.

    PubMed  CAS  Google Scholar 

  • Bell, C., Abrams, J., and Nutt, D. 2001. Tryptophan depletion and its implications for psychiatry. Br. J. Psychiatry 178:399–405.

    Article  PubMed  CAS  Google Scholar 

  • Benkert, O., Grunder, G., Wetzel, H., and Hackett, D. 1996. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J. Psychiatr. Res. 30:441–451.

    Article  PubMed  CAS  Google Scholar 

  • Benkert, O., Szegedi, A., and Kohnen, R. 2000. Mirtazapine compared with paroxetine in major depression. J. Clin. Psychiatry 61:656–663.

    Article  PubMed  CAS  Google Scholar 

  • Bergqvist, P.B., Hjorth, S., Audet, R.M., Apelqvist, G., Bengtsson, F., and Butterworth, R.F. 1996. Ammonium acetate challenge in experimental chronic hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo. Eur. Neuropsychopharmacol. 6:317–322.

    Article  PubMed  Google Scholar 

  • Berk, M., Plein, H., and Ferreira, D. 2001. Platelet glutamate receptor supersensitivity in major depressive disorder. Clin. Neuropharmacol. 24:129–132.

    Article  PubMed  CAS  Google Scholar 

  • Berton, O. and Nestler, E.J. 2006. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7:137–151.

    Article  PubMed  CAS  Google Scholar 

  • Bertsch, T., Mielke, O., Höly, S., Zimmer, W., Casarin, W., Aufenanger, J., Walter, S., Muehlhauser, F., Kuehl, S., Ragoschke, A., and Fassbender, K. 2001. Homocysteine in cerebrovascular disease: an independent risk factor for subcortical vascular encephalopathy. Clin Chem Lab Med 39:721–724.

    PubMed  CAS  Google Scholar 

  • Bilici, M., Efe, H., Koroglu, M.A., Uydu, H.A., Bekaroglu, M., and Deger, O. 2001. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 64:43–51.

    Article  PubMed  CAS  Google Scholar 

  • Blier, P. 2003. The pharmacology of putative early-onset antidepressant strategies. Eur. Neuropsychopharmacol. 13:57–66.

    Article  PubMed  CAS  Google Scholar 

  • Booij, L., Van der Does, A.J., and Riedel, W.J. 2003. Monoamine depletion in psychiatric and healthy populations: review. Mol. Psychiatry 8:951–973.

    Article  PubMed  CAS  Google Scholar 

  • Borkowska, H.D., Oja, S.S., Oja, O.S., Saransaari, P., Hilgier, W., and Albrecht, J. 1999. N-methyl-d-aspartate-evoked changes in the striatal extracellular levels of dopamine and its metabolites in vivo in rats with acute hepatic encephalopathy. Neurosci. Lett. 268:151–154.

    Article  PubMed  CAS  Google Scholar 

  • Bottiglieri, T. 2005. Homocysteine and folate metabolism in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29:1103–1112.

    Article  PubMed  CAS  Google Scholar 

  • Boyer, P.A., Skolnick, P., and Fossom, L.H. 1998. Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study. J. Mol. Neurosci. 10:219–233.

    Article  PubMed  CAS  Google Scholar 

  • Cangiano, C., Cardelli-Cangiano, P., James, J.H., Rossi-Fanelli, F., Patrizi, M.A., Brackett, K.A., Strom, R., and Fischer, J.E. 1983. Brain microvessels take up large neutral amino acids in exchange for glutamine. Cooperative role of Na+-dependent and Na+-independent systems. J. Biol. Chem. 258:8949–8954.

    PubMed  CAS  Google Scholar 

  • Capuron, L. and Dantzer, R. 2003. Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 17(Suppl. 1):S119–S124.

    Article  PubMed  CAS  Google Scholar 

  • Carpenter, L.L., Yasmin, S., and Price, L.H. 2002. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol. Psychiatry 51:183–188.

    Article  PubMed  CAS  Google Scholar 

  • Cauli, O., Rodrigo, R., Piedrafita, B., Boix, J., and Felipo, V. 2007. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46:51–519.

    Article  PubMed  CAS  Google Scholar 

  • Chamberlin, E. and Tsai, G.E. 1998. A glutamatergic model of ECT-induced memory dysfunction. Harv Rev Psychiatry 5:307–317.

    Article  PubMed  CAS  Google Scholar 

  • Chan, K.H., Cheung, R.T., Au-Yeung, K.M., Mak, W., Cheng, T.S., and Ho, S.L. 2005. Wilson’s disease with depression and parkinsonism. J. Clin. Neurosci. 12:303–305.

    Article  PubMed  CAS  Google Scholar 

  • Chen, F., Larsen, M.B., Sanchez, C., and Wiborg, O. 2005. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors. Eur. Neuropsychopharmacol. 15:193–198.

    Article  PubMed  CAS  Google Scholar 

  • Chrapko, W.E., Jurasz, P., Radomski, M.W., Lara, N., Archer, S.L., and Le Melledo, J.M. 2004. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol. Psychiatry 56:129–134.

    Article  PubMed  CAS  Google Scholar 

  • Ciranna, L. 2006. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological function in pathology. Curr. Neuropharmacol. 4:101–114.

    Article  PubMed  CAS  Google Scholar 

  • Compton, M.T. and Nemeroff, C.B. 2000. The treatment of bipolar depression. J. Clin. Psychiatry 61(Suppl. 9):57–67.

    PubMed  CAS  Google Scholar 

  • Cooper, J.R., Bloom, F.E., and Roth, R.H. 1996. The Biochemical Basis of Neuropharmacology. New York: Oxford University Press.

    Google Scholar 

  • D’Sa, C. and Duman, R.S. 2002. Antidepressants and neuroplasticity. Bipolar Disord. 4:183–194.

    Article  PubMed  Google Scholar 

  • Dager, S.R., Friedman, S.D., Parow, A., Demopulos, C., Stoll, A.L., Lyoo, I.K., Dunner, D.L., and Renshaw, P.F. 2004. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 61:450–458.

    Article  PubMed  CAS  Google Scholar 

  • Dall’Olio, R., Gandolfi, O., and Gaggi, R. 2000. d-Cycloserine, a positive modulator of NMDA receptors, inhibits serotonergic function. Behav. Pharmacol. 11:631–637.

    Article  PubMed  Google Scholar 

  • Dantzer, R. 2001. Cytokine-induced sickness behavior: where do we stand? Brain Behav. Immun. 15:7–24.

    Article  PubMed  CAS  Google Scholar 

  • Delgado, P.L., Miller, H.L., Salomon, R.M., Licinio, J., Krystal, J.H., Moreno, F.A., Heninger, G.R., and Charney, D.S. 1999. Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action. Biol. Psychiatry 46:212–220.

    Article  PubMed  CAS  Google Scholar 

  • Devanand, D.P., Shapira, B., Petty, F., Kramer, G., Fitzsimons, L., Lerer, B., and Sackeim, H.A. 1995. Effects of electroconvulsive therapy on plasma GABA. Convulsive Ther. 11:3–13.

    Google Scholar 

  • Di Cara, B., Dusticier, N., Forni, C., Lievens, J.C., and Daszuta, A. 2001. Serotonin depletion produces long lasting increase in striatal glutamatergic transmission. J. Neurochem. 78:240–248.

    Article  PubMed  CAS  Google Scholar 

  • Di Martini, A., Dew, M.A., Javed, L., Fitzgerald, M.G., Jain, A., and Day, N. 2004. Pretransplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant. Psychosomatics 45:517–523.

    Article  Google Scholar 

  • Dimopoulos, N., Piperi, C., Salonicioti, A., Psarra, V., Gazi, F., Papadimitriou, A., Lea, R.W., and Kalofoutis, A. 2007. Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek population. Clin Biochem 40:60–608.

    Article  PubMed  CAS  Google Scholar 

  • Domek-Łopacíska, K. and Strosznajder, J.B. 2005. Cyclic GMP metabolism and its role in brain physiology. J. Physiol. Pharmacol. 56(Suppl. 2):15–34.

    Google Scholar 

  • Drevets, W.C., Thase, M.E., Moses-Kolko, E.L., Price, J., Frank, E., Kupfer, D.J., and Mathis, C. 2007. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34:865–877.

    Article  PubMed  CAS  Google Scholar 

  • Dunn, A. 2001. Effects of cytokines and infections on brain neurochemistry. In Psycho­neuroimmunology, ed. R. Ader, D. Felten, and N. Cohen, pp. 649–666. San Diego: Academic.

    Google Scholar 

  • Eggers, B., Hermann, W., Barthel, H., Sabri, O., Wagner, A., and Hesse, S. 2003. The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson’s disease. J. Neurol. 250:576–580.

    Article  PubMed  CAS  Google Scholar 

  • Engelmann, M., Wolf, G., and Horn, T.F. 2002. Release patterns of excitatory and inhibitory amino acids within the hypothalamic supraoptic nucleus in response to direct nitric oxide administration during forced swimming in rats. Neurosci. Lett. 324:252–254.

    Article  PubMed  CAS  Google Scholar 

  • Entsuah, R., Derivan, A., and Kikta, D. 1998. Early onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients. Clin. Ther. 20:517–526.

    Article  PubMed  CAS  Google Scholar 

  • Erceg, S., Monfort, P., Hernandez-Viadel, M., Rodrigo, R., Montoliu, C., and Felipo, V. 2005. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 41:299–306.

    Article  PubMed  CAS  Google Scholar 

  • Felipo, V., Grau, E., Minana, M.D., and Grisolia, S. 1993. Hyperammonemia decreases protein-kinase-C-dependent phosphorylation of microtubule-associated protein 2 and increases its binding to tubulin. Eur. J. Biochem. 214:243–249.

    Article  PubMed  CAS  Google Scholar 

  • Folstein, M., Liu, T., Peter, I., Buell, J., Arsenault, L., Scott, T., and Qiu, W.W. 2007. The homocysteine hypothesis of depression. Am J Psychiatry 164:861–867.

    Article  PubMed  Google Scholar 

  • Forton, D.M., Thomas, H.C., and Taylor-Robinson, S.D. 2004. Central nervous system involvement in hepatitis C virus infection. Metab. Brain Dis. 19:383–391.

    Article  PubMed  Google Scholar 

  • Frankenburg, F.R. 2007. The role of one-carbon metabolism in schizophrenia and depression. Harv Rev Psychiatry 15:146–160.

    Article  PubMed  Google Scholar 

  • Frieling, H., Romer, K.D., Beyer, S., Hillemacher, T., Wilhelm, J., Jacoby, G.E., de Zwaan, M., Kornhuber, J., and Bleich, S. 2006. Depressive symptoms may explain elevated plasma levels of homocysteine in females with eating disorders. J Psychiatr Res, Dec 18; doi:10.1016/j.jpsychires.2006.10.007 [Epub ahead of print].

    Google Scholar 

  • Gammal, S.H., Basile, A.S., Geller, D., Skolnick, P., and Jones, E.A. 1990. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 11:371–378.

    Article  PubMed  CAS  Google Scholar 

  • Gardner, A., Johansson, A., Wibom, R., Nennesmo, I., von Dobeln, U., Hagenfeldt, L., and Hallstrom, T. 2003. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J. Affect. Disord. 76:55–68.

    Article  PubMed  CAS  Google Scholar 

  • Geddes, J.R., Freemantle, N., Mason, J., Eccles, M.P., and Boynton, J. 2000. SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst. Rev. CD001851.

    Google Scholar 

  • Guelfi, J.D., White, C., Hackett, D., Guichoux, J.Y., and Magni, G. 1995. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia. J. Clin. Psychiatry 56:450–458.

    PubMed  CAS  Google Scholar 

  • Gutiérrez-Aguilar, G., Abenia-Usón, P., García-Cazorla, A., Vilaseca, M.A., and Campistol, J. 2005. Encephalopathy with methylmalonic aciduria and homocystinuria secondary to a deficient exogenous supply of vitamin B12. Rev. Neurol. 40:605–608.

    PubMed  Google Scholar 

  • Ha, J.H. and Basile, A.S. 1996. Modulation of ligand binding to components of the GABAA receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes. Brain Res. 720:35–44.

    Article  PubMed  CAS  Google Scholar 

  • Harkin, A.J., Bruce, K.H., Craft, B., and Paul, I.A. 1999. Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 372:207–213.

    Article  PubMed  CAS  Google Scholar 

  • Harkin, A., Connor, T.J., Burns, M.P., and Kelly, J.P. 2004. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 14:27–281.

    Article  PubMed  CAS  Google Scholar 

  • Harkin, A., Nowak, G., and Paul, I.A. 2000. Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors. Eur. J. Pharmacol. 389:187–192.

    Article  PubMed  CAS  Google Scholar 

  • Harvey, B.H. 1996. Affective disorders and nitric oxide: a role in pathways to relapse and refractoriness. Hum. Psychopharmacol. 11:309–319.

    Article  CAS  Google Scholar 

  • Harvey, B.H., Jonker, L.P., Brand, L., Heenop, M., and Stein, D.J. 2002. NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus. Life Sci. 71:43–54.

    Article  PubMed  CAS  Google Scholar 

  • Harvey, B.H., McEwen, B.S., and Stein, D.J. 2003. Neurobiology of antidepressant withdrawal: implications for the longitudinal outcome of depression. Biol. Psychiatry 54:1105–1117.

    Article  PubMed  CAS  Google Scholar 

  • Harvey, B.H., Oosthuizen, F., Brand, L., Wegener, G., and Stein, D.J. 2004. Stress–restress evokes sustained iNOS activity and altered GABA levels and NMDA receptors in rat hippocampus. Psychopharmacology (Berl.) 175:49–502.

    Article  CAS  Google Scholar 

  • Harvey, B.H., Retief, R., Korff, A., and Wegener, G. 2006. Increased hippocampal nitric oxide synthase activity and stress responsiveness after imipramine discontinuation: role of 5HT 2A/C-receptors. Metab. Brain Dis. 21:211–220.

    Article  PubMed  CAS  Google Scholar 

  • Heiberg, I.L., Wegener, G., and Rosenberg, R. 2002. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain Res. 134:479–484.

    Article  PubMed  CAS  Google Scholar 

  • Heresco-Levy, U., Javitt, D.C., Gelfin, Y., Gorelik, E., Bar, M., Blanaru, M., and Kremer, I. 2006. Controlled trial of d-cycloserine adjuvant therapy for treatment-resistant major depressive disorder. J. Affect. Disord. 93:239–243.

    Article  PubMed  CAS  Google Scholar 

  • Hesse, S., Barthel, H., Hermann, W., Murai, T., Kluge, R., Wagner, A., Sabri, O., and Eggers, B. 2003. Regional serotonin transporter availability and depression are correlated in Wilson’s disease. J. Neural Transm. 110:923–933.

    Article  PubMed  CAS  Google Scholar 

  • Hilgier, W., Puka, M., and Albrecht, J. 1992. Characteristics of large neutral amino acid-induced release of preloaded l-glutamine from rat cerebral capillaries in vitro: effects of ammonia, hepatic encephalopathy, and gamma-glutamyl transpeptidase inhibitors. J. Neurosci. Res. 32:221–226.

    Article  PubMed  CAS  Google Scholar 

  • House, J.D., Jacobs, R.L., Stead, L.M., Brosnan, M.E., and Brosnan, J.T. 1999. Regulation of homocysteine metabolism. Adv. Enzyme Regul. 39:69–91.

    Article  PubMed  CAS  Google Scholar 

  • Ishizuka, Y., Ishida, Y., Jin, Q.H., Mitsuyama, Y., and Kannan, H. 2000. GABA(A) and GABA(B) receptors modulating basal and footshock-induced nitric oxide releases in rat prefrontal cortex. Brain Res. 872:266–270.

    Article  PubMed  CAS  Google Scholar 

  • Jones, E.A. 2002. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab. Brain Dis. 17:275–281.

    Article  PubMed  CAS  Google Scholar 

  • Kaneko, K., Kurumaji, A., Watanabe, A., Yamada, S., and Toru, M. 1998. Changes in high K+-evoked serotonin release and serotonin 2A/2C receptor binding in the frontal cortex of rats with thioacetamide-induced hepatic encephalopathy. J. Neural Transm. 105:13–30.

    Article  PubMed  CAS  Google Scholar 

  • Kasper, S., Spadone, C., Verpillat, P., and Angst, J. 2006. Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis. Int. Clin. Psychopharmacol. 21:105–110.

    Article  PubMed  Google Scholar 

  • Kendler, K.S., Thornton, L.M., and Gardner, C.O. 2001. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am. J. Psychiatry 158:582–586.

    Article  PubMed  CAS  Google Scholar 

  • Kim, Y.K., Paik, J.W., Lee, S.W., Yoon, D., Han, C., and Lee, B.H. 2006. Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 30:1091–1096.

    Article  PubMed  CAS  Google Scholar 

  • Kocsis, J.H. 2003. Pharmacotherapy for chronic depression. J. Clin. Psychol. 59:885–892.

    Article  PubMed  Google Scholar 

  • Kosenko, E., Kaminsky, Y., Grau, E., Minana, M.D., Grisolia, S., and Felipo, V. 1995. Nitroarginine, an inhibitor of nitric oxide synthetase, attenuates ammonia toxicity and ammonia-induced alterations in brain metabolism. Neurochem. Res. 20:451–456.

    Article  PubMed  CAS  Google Scholar 

  • Kosenko, E., Kaminsky, Y., Grau, E., Minana, M.D., Marcaida, G., Grisolia, S., and Felipo, V. 1994. Brain ATP depletion induced by acute ammonia intoxication in rats is mediated by activation of the NMDA receptor and Na+,K(+)-ATPase. J. Neurochem. 63:2172–2178.

    Article  PubMed  CAS  Google Scholar 

  • Kosenko, E., Kaminsky, Y., Lopata, O., Muravyov, N., Kaminsky, A., Hermenegildo, C., and Felipo, V. 1998. Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication. Metab. Brain Dis. 13:29–41.

    Article  PubMed  CAS  Google Scholar 

  • Kroczka, B., Branski, P., Palucha, A., Pilc, A., and Nowak, G. 2001. Antidepressant-like properties of zinc in rodent forced swim test. Brain Res. Bull. 55:297–300.

    Article  PubMed  CAS  Google Scholar 

  • Kruse, J., Petrak, F., Herpertz, S., Albus, C., Lange, K., and Kulzer, B. 2006. Diabetes and depression – a life-endangering interaction. Z. Psychosom. Med. Psychother. 52:289–309.

    PubMed  Google Scholar 

  • Krystal, J.H., Sanacora, G., Blumberg, H., Anand, A., Charney, D.S., Marek, G., Epperson, C.N., Goddard, A., and Mason, G.F. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 7(Suppl. 1):S71–S80.

    Article  PubMed  CAS  Google Scholar 

  • Law, A.J. and Deakin, J.F. 2001. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. Neuroreport 12:2971–2974.

    Article  PubMed  CAS  Google Scholar 

  • Leinonen, E., Skarstein, J., Behnke, K., Agren, H., and Helsdingen, J.T. 1999. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group. Int. Clin. Psychopharmacol. 14:329–337.

    Article  PubMed  CAS  Google Scholar 

  • Leonard, B.E. 2003. Fundamentals of Psychopharmacology. Chichester: Wiley.

    Book  Google Scholar 

  • Levine, J., Sela, B.A., Osher, Y., and Belmaker, R.H. 2005. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 29:1181–1191.

    Article  PubMed  CAS  Google Scholar 

  • Lipton, S.A., Kim, W.K., Choi, Y.B., Kumar, S., D’Emilia, D.M., Rayudu, P.V., Arnelle, D.R., and Stamler, J.S. 1997. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc. Natl Acad. Sci. USA 94:5923–5928.

    Article  PubMed  CAS  Google Scholar 

  • Madrigal, J.L., Garcia-Bueno, B., Caso, J.R., Perez-Nievas, B.G., and Leza, J.C. 2006. Stress-induced oxidative changes in brain. CNS Neurol. Disord. Drug Targets 5:561–568.

    Article  PubMed  Google Scholar 

  • Maes, M., D’Haese, P.C., Scharpe, S., D’Hondt, P., Cosyns, P., and De Broe, M.E. 1994. Hypozincemia in depression. J. Affect. Disord. 31:135–140.

    Article  PubMed  CAS  Google Scholar 

  • Maes, M., Verkerk, R., Vandoolaeghe, E., Lin, A., and Scharpe, S. 1998. Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatr. Scand. 97:302–308.

    Article  PubMed  CAS  Google Scholar 

  • Manji, H.K., Drevets, W.C., and Charney, D.S. 2001. The cellular neurobiology of depression. Nat. Med. 7:541–547.

    Article  PubMed  CAS  Google Scholar 

  • McDaniel, W.W., Sahota, A.K., Vyas, B.V., Laguerta, N., Hategan, L., and Oswald, J. 2006. Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J. ECT 22:103–106.

    Article  PubMed  CAS  Google Scholar 

  • McLeod, T.M., Lopez-Figueroa, A.L., and Lopez-Figueroa, M.O. 2001. Nitric oxide, stress, and depression. Psychopharmacol. Bull. 35:2–41.

    PubMed  CAS  Google Scholar 

  • Michalak, A., Chatauret, N., and Butterworth, R.F. 2001. Evidence for a serotonin transporter deficit in experimental acute liver failure. Neurochem. Int. 38:163–68.

    Article  PubMed  CAS  Google Scholar 

  • Michalak, A., Rose, C., Butterworth, J., and Butterworth, R.F. 1996. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology 24:908–913.

    Article  PubMed  CAS  Google Scholar 

  • Miller, A.H., Capuron, L., and Raison, C.L. 2005. Immunologic influences on emotion regulation. Clin. Neurosci. Res. 4:325–333.

    Article  Google Scholar 

  • Mitchell, A.J. 2006. Two-week delay in onset of action of antidepressants: new evidence. Br. J. Psychiatry 188:105–106.

    Article  PubMed  Google Scholar 

  • Montoliu, C., Piedrafita, B., Serra, M.A., del Olmo, J.A., Rodrigo, J.M., and Felipo, V. 2007. A single transient episode of hyperammonemia induces long-lasting alterations in protein kinase A. Am. J. Physiol Gastrointest Liver Physiol 292: G305–14.

    Article  CAS  Google Scholar 

  • Mousseau, D.D., Baker, G.B., and Butterworth, R.F. 1997. Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. J. Neurochem. 68:1200–1208.

    Article  PubMed  CAS  Google Scholar 

  • Mousseau, D.D., Perney, P., Layrargues, G.P., and Butterworth, R.F. 1993. Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy. Neurosci. Lett. 162:192–196.

    Article  PubMed  CAS  Google Scholar 

  • Muller, N., Schwarz, M.J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Muller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., Moller, H.J., Arolt, V., and Riedel, M. 2006. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol. Psychiatry 11:680–684.

    Article  PubMed  CAS  Google Scholar 

  • Nelson, J.C., Mazure, C.M., Jatlow, P.I., Bowers, M.B., Jr., and Price, L.H. 2004. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biol. Psychiatry 55:296–300.

    Article  PubMed  CAS  Google Scholar 

  • Nilsson, K., Gustafson, L., and Hultberg, B. 2007. Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis. Dement. Geriatr. Cogn. Disord. 24:162–168.

    Article  PubMed  CAS  Google Scholar 

  • Norenberg, M.D. and Martinez-Hernandez, A. 1979. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res. 161:303–310.

    Article  PubMed  CAS  Google Scholar 

  • Norris, E.R., Smallwood, G.A., Connor, K., McDonell, K., Martinez, E., Stieber, A.C., and Heffron, T.G. 2002. Prevalence of depressive symptoms in patients being evaluated for liver transplantation. Transplant. Proc. 34:3285–3286.

    Article  PubMed  CAS  Google Scholar 

  • Nowak, G., Ordway, G.A., and Paul, I.A. 1995. Alterations in the N-methyl-d-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 675:157–164.

    Article  PubMed  CAS  Google Scholar 

  • Ohkuma, S., Narihara, H., Katsura, M., Hasegawa, T., and Kuriyama, K. 1995. Nitric oxide-induced [3H] GABA release from cerebral cortical neurons is mediated by peroxynitrite. J. Neurochem. 65:1109–1114.

    Article  PubMed  CAS  Google Scholar 

  • Olasmaa, M., Rothstein, J.D., Guidotti, A., Weber, R.J., Paul, S.M., Spector, S., Zeneroli, M.L., Baraldi, M., and Costa, E. 1990. Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J. Neurochem. 55:2015–2023.

    Article  PubMed  CAS  Google Scholar 

  • Packman, W., Wilson, C.T., Riesner, A., Fairley, C., and Packman, S. 2006. Psychological complications of patients with Gaucher disease. J. Inherit. Metab. Dis. 29:99–105.

    Article  PubMed  CAS  Google Scholar 

  • Pandey, G.N., Conley, R.R., Pandey, S.C., Goel, S., Roberts, R.C., Tamminga, C.A., Chute, D., and Smialek, J. 1997. Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects. Psychiatry Res. 71:137–149.

    Article  PubMed  CAS  Google Scholar 

  • Perez, V., Gilaberte, I., Faries, D., Alvarez, E., and Artigas, F. 1997. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349:159–1597.

    Article  PubMed  CAS  Google Scholar 

  • Perlmutter, J.B., Frishman, W.H., and Feinstein, R.E. 2000. Major depression as a risk factor for cardiovascular disease: therapeutic implications. Heart Dis. 2:75–82.

    PubMed  CAS  Google Scholar 

  • Prast, H. and Philippu, A. 2001. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64:51–68.

    Article  PubMed  CAS  Google Scholar 

  • Rao, V.L. and Butterworth, R.F. 1994. Alterations of [3H]8-OH-DPAT and [3H]ketanserin binding sites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurosci. Lett. 182:69–72.

    Article  PubMed  CAS  Google Scholar 

  • Rao, V.L., Giguere, J.F., Layrargues, G.P., and Butterworth, R.F. 1993. Increased activities of MAOA and MAOB in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Brain Res. 621:349–352.

    Article  PubMed  CAS  Google Scholar 

  • Ratnakumari, L., Audet, R., Qureshi, I.A., and Butterworth, R.F. 1995. Na+,K(+)-ATPase activities are increased in brain in both congenital and acquired hyperammonemic syndromes. Neurosci. Lett. 197:89–92.

    Article  PubMed  CAS  Google Scholar 

  • Regenold, W.T., Hisley, K.C., Obuchowski, A., Lefkowitz, D.M., Marano, C., and Hauser, P. 2005. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites – a pilot study in treatment-resistant affective disorder patients. J. Affect. Disord. 85:341–350.

    Article  PubMed  CAS  Google Scholar 

  • Regenold, W.T., Phatak, P., Kling, M.A., and Hauser, P. 2004. Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders. Mol. Psychiatry 9:731–733.

    Article  PubMed  CAS  Google Scholar 

  • Riedel, G., Platt, B., and Micheau, J. 2003. Glutamate receptor function in learning and memory. Behav. Brain Res. 140:1–47.

    Article  PubMed  CAS  Google Scholar 

  • Rogoz, Z., Dziedzicka-Wasylewska, M., Daniel, W.A., Wojcikowski, J., Dudek, D., Wrobel, A., and Zieba, A. 2004. Effects of joint administration of imipramine and amantadine in patients with drug-resistant unipolar depression. Pol. J. Pharmacol. 56:735–742.

    Article  PubMed  CAS  Google Scholar 

  • Rogoz, Z., Skuza, G., Maj, J., and Danysz, W. 2002. Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 42:102–1030.

    Article  PubMed  CAS  Google Scholar 

  • Rozanski, A., Blumenthal, J.A., and Kaplan, J. 1999. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99:2192–2217.

    Article  PubMed  CAS  Google Scholar 

  • Sadek, J., Shellhaas, R., Camfield, C.S., Camfield, P.R., and Burley, J. 2004. Psychiatric findings in four female carriers of Fabry disease. Psychiatr. Genet. 14:199–201.

    Article  PubMed  Google Scholar 

  • Sanacora, G., Mason, G.F., Rothman, D.L., Hyder, F., Ciarcia, J.J., Ostroff, R.B., Berman, R.M., and Krystal, J.H. 2003. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry 160:577–579.

    Article  PubMed  Google Scholar 

  • Sanchez, C. 2006. The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram. Basic Clin. Pharmacol. Toxicol. 99:91–95.

    Article  PubMed  CAS  Google Scholar 

  • Sapolsky, R.M. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57:925–935.

    Article  PubMed  CAS  Google Scholar 

  • Saran, T., Hilgier, W., Kocki, T., Urbanska, E.M., Turski, W.A., and Albrecht, J. 1998. Acute ammonia treatment in vitro and in vivo inhibits the synthesis of a neuroprotectant kynurenic acid in rat cerebral cortical slices. Brain Res. 787:348–350.

    Article  PubMed  CAS  Google Scholar 

  • Saransaari, P. and Oja, S.S. 1997. Enhanced GABA release in cell-damaging conditions in the adult and developing mouse hippocampus. Int. J. Dev. Neurosci. 15:163–174.

    Article  PubMed  CAS  Google Scholar 

  • Sargent, P.A., Kjaer, K.H., Bench, C.J., Rabiner, E.A., Messa, C., Meyer, J., Gunn, R.N., Grasby, P.M., and Cowen, P.J. 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57:17–180.

    Article  PubMed  CAS  Google Scholar 

  • Schliess, F., Gorg, B., and Haussinger, D. 2006. Pathogenetic interplay between osmotic and oxidative stress: the hepatic encephalopathy paradigm. Biol. Chem. 387:1363–1370.

    Article  PubMed  CAS  Google Scholar 

  • Scollo-Lavizzari, G. and Steinmann, E. 1985. Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1:132–1325.

    Article  Google Scholar 

  • Shiah, I.S. and Yatham, L.N. 1998. GABA function in mood disorders: an update and critical review. Life Sci. 63:1289–1303.

    Article  PubMed  CAS  Google Scholar 

  • Skolnick, P. 1999. Antidepressants for the new millennium. Eur. J. Pharmacol. 375:31–40.

    Article  PubMed  CAS  Google Scholar 

  • Skolnick, P., Layer, R.T., Popik, P., Nowak, G., Paul, I.A., and Trullas, R. 1996. Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 29:23–26.

    Article  PubMed  CAS  Google Scholar 

  • Stahl, S. 1996. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge: Cambridge University Press.

    Google Scholar 

  • Stahl, S.M., Nierenberg, A.A., and Gorman, J.M. 2001. Evidence of early onset of antidepressant effect in randomized controlled trials. J. Clin. Psychiatry 62(Suppl. 4):17–23.

    PubMed  CAS  Google Scholar 

  • Starkman, M.N., Gebarski, S.S., Berent, S., and Schteingart, D.E. 1992. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing’s syndrome. Biol. Psychiatry 32:756–765.

    Article  PubMed  CAS  Google Scholar 

  • Starkman, M.N., Giordani, B., Berent, S., Schork, M.A., and Schteingart, D.E. 2001. Elevated cortisol levels in Cushing’s disease are associated with cognitive decrements. Psychosom. Med. 63:985–993.

    PubMed  CAS  Google Scholar 

  • Starkman, M.N., Giordani, B., Gebarski, S.S., Berent, S., Schork, M.A., and Schteingart, D.E. 1999. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing’s disease. Biol. Psychiatry 46:1595–1602.

    Article  PubMed  CAS  Google Scholar 

  • Stewart, C.A. and Reid, I.C. 2002. Antidepressant mechanisms: functional and molecular correlates of excitatory amino acid neurotransmission. Mol. Psychiatry 7(Suppl. 1):S15–S22.

    Article  PubMed  CAS  Google Scholar 

  • Stryjer, R., Strous, R.D., Shaked, G., Bar, F., Feldman, B., Kotler, M., Polak, L., Rosenzcwaig, S., and Weizman, A. 2003. Amantadine as augmentation therapy in the management of treatment-resistant depression. Int. Clin. Psychopharmacol. 18:93–96.

    Article  PubMed  Google Scholar 

  • Suzuki, E., Yagi, G., Nakaki, T., Kanba, S., and Asai, M. 2001. Elevated plasma nitrate levels in depressive states. J. Affect. Disord. 63:221–224.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki, E., Yoshida, Y., Shibuya, A., and Miyaoka, H. 2003. Nitric oxide involvement in depression during interferon-alpha therapy. Int. J. Neuropsychopharmacol. 6:415–419.

    Article  PubMed  CAS  Google Scholar 

  • Tagliaferro, P., Ramos, A.J., Lopez-Costa, J.J., Lopez, E.M., Saavedra, J.P., and Brusco, A. 2001. Increased nitric oxide synthase activity in a model of serotonin depletion. Brain Res. Bull. 54:199–205.

    Article  PubMed  CAS  Google Scholar 

  • Tao, R. and Auerbach, S.B. 2000. Regulation of serotonin release by GABA and excitatory amino acids. J. Psychopharmacol. 14:100–113.

    Article  PubMed  CAS  Google Scholar 

  • Thompson, C. 2002. Onset of action of antidepressants: results of different analyses. Hum. Psychopharmacol. 17(Suppl. 1):S27–S32.

    Article  PubMed  CAS  Google Scholar 

  • Tome, M.B., Isaac, M.T., Harte, R., and Holland, C. 1997. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int. Clin. Psychopharmacol. 12:81–89.

    Article  PubMed  CAS  Google Scholar 

  • Vaquero, J. and Butterworth, R.F. 2006. The brain glutamate system in liver failure. J. Neurochem. 98:661–669.

    Article  PubMed  CAS  Google Scholar 

  • Vester-Blokland, E. and Van Oers, H. 2002. Mirtazapine orally disintegrating tablets versus sertraline: response and remission in a prospective onset-of-action trial. Eur. Neuropsychopharmacol. 12:S186.

    Article  Google Scholar 

  • Vogels, B.A., Maas, M.A., Daalhuisen, J., Quack, G., and Chamuleau, R.A. 1997. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 25:820–827.

    Article  PubMed  CAS  Google Scholar 

  • Wegener, G., Volke, V., Harvey, B.H., and Rosenberg, R. 2003. Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity. Brain Res. 959:128–134.

    Article  PubMed  CAS  Google Scholar 

  • Wheatley, D.P., van Moffaert, M., Timmerman, L., and Kremer, C.M. 1998. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine–Fluoxetine Study Group. J. Clin. Psychiatry 59:306–312.

    Article  CAS  Google Scholar 

  • Wheeler, D., Boutelle, M.G., and Fillenz, M. 1995. The role of N-methyl-d-aspartate receptors in the regulation of physiologically released dopamine. Neuroscience 65:767–774.

    Article  PubMed  CAS  Google Scholar 

  • Wichers, M.C. and Maes, M. 2004. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J. Psychiatry Neurosci. 29:11–17.

    PubMed  Google Scholar 

  • Wysmyk, U., Oja, S.S., Saransaari, P., and Albrecht, J. 1992. Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy. Neurochem. Res. 17:1187–1190.

    Article  PubMed  CAS  Google Scholar 

  • Yamada, J., Saitow, F., Satake, S., Kiyohara, T., and Konishi, S. 1999. GABA(B) receptor-mediated presynaptic inhibition of glutamatergic and GABAergic transmission in the basolateral amygdala. Neuropharmacology 38:1743–1753.

    Article  PubMed  CAS  Google Scholar 

  • Yurdaydin, C., Herneth, A.M., Puspok, A., Steindl, P., Singer, E., and Ferenci, P. 1996. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists. Eur. J. Gastroenterol. Hepatol. 8:667–671.

    PubMed  CAS  Google Scholar 

  • Zanardi, R., Serretti, A., Rossini, D., Franchini, L., Cusin, C., Lattuada, E., Dotoli, D., and Smeraldi, E. 2001. Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. Biol. Psychiatry 50:323–330.

    Article  PubMed  CAS  Google Scholar 

  • Zarate, C.A., Jr., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., and Manji, H.K. 2006. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 63:856–864.

    Article  PubMed  CAS  Google Scholar 

  • Zieve, L. 1987. Pathogenesis of hepatic encephalopathy. Metab. Brain Dis. 2:147–165.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The author’s work in the area of depression and stress is supported by the South African Medical Research Council (MRC) and the National Research Foundation (grant number 2073038).

Author information

Authors and Affiliations

  1. Division of Pharmacology, School of Pharmacy, North-West University, Potchefstroom, South Africa

    Brian H. Harvey

Authors
  1. Brian H. Harvey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medicine & Science, Chicago Medical School, Rosalind Franklin University of, Green Bay Rd. 3333, North Chicago, 60064, Illinois, USA

    David W. McCandless

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Harvey, B.H. (2009). Major Depression and Metabolic Encephalopathy: Syndromes More Alike Than Not?. In: McCandless, D. (eds) Metabolic Encephalopathy. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79112-8_18

Download citation

Publish with us

Policies and ethics

Search

Navigation